Dr. Swenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Cedar St
Lmp1080
New Haven, CT 06520Phone+1 203-785-4138Fax+1 203-785-7273
Education & Training
- Yale-New Haven Medical CenterFellowship, Gastroenterology, 2001 - 2005
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1999 - 2002
- University of Cincinnati College of MedicineClass of 1999
- University of Cincinnati College of MedicineClass of 1999
Certifications & Licensure
- CT State Medical License 2002 - 2025
- NY State Medical License 1988 - 2016
Publications & Presentations
PubMed
- 28 citationsShort-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)Mark S. Sulkowski, Steve Flamm, Zeid Kayali, Eric Lawitz, Paul Y. Kwo
Liver International. 2017-06-01 - 65 citationsDetermination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral contentArijeet K. Gattu, E. Scott Swenson, Yasuko Iwakiri, Varman T. Samuel, Nancy Troiano
FASEB Journal. 2013-07-25 - 337 citationsDaclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrenceFred Poordad, Eugene R. Schiff, John M. Vierling, Charles S. Landis, Robert J. Fontana
Hepatology. 2016-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: